Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

24 May 2017, Bangkok – This April and May, the targeted malaria elimination (TME) study in Laos’ final prevalence survey evaluated new tools to detect asymptomatic malaria. These included new rapid diagnostic tests (RDTs) that may be similar in sensitivity to a PCR performed on dried blood spots and reading machines that fire a laser at RDTs and use a thermal camera to detect faint positive results that would be beyond the range of the human eye.

Composite photo of researchers participating in the targeted malaria elimination study in Lao

Developed by Intellectual Ventures Laboratory with support from the Bill and Melinda Gates Foundation via Global Good, both are potential new malaria elimination tools as they could identify rapidly the asymptomatic reservoir of falciparum infections. Results are expected late summer 2017 comparing the new RDTs and readers to a gold standard method of malaria detection, the quantitative PCR results from Mallika Imwong’s molecular laboratory at MORU.

A team led by LOMWRU scientists Mayfong Mayxay and Koukeo Phommasone (bottom right), Tiengkham Pongvongsa (bottom centre), head of malaria control in Savannakhet Province, and WWARN’s Mehul Dhorda and MORU’s Lorenz von Seidlein and Tom Peto hosted Kevin Nichols and Stephen Burkhor (top left) of Intellectual Ventures Laboratory (IVL) to field test the tools.

Funded by the Bill and Melinda Gates Foundation, the MORU TME project seeks to accelerate malaria elimination by providing mass drug administrations (MDA) to communities that have relatively high P. falciparum prevalence, access to village health malaria workers and where every household has one or more long lasting insecticide treated bed nets. The TME project operates in four Greater Mekong Subregion countries: Myanmar, Cambodia, Laos and Viet Nam.

In Laos, the TME project focuses on rural villages in Savannakhet province, which has the third highest malaria incidence in Lao PDR. A survey conducted in 18 rural villages in Savannakhet in 2015 using uPCR detected Plasmodium infections in 175 of 888 samples (20%). Most villages in Savannakhet are relatively accessible and malaria elimination has a high priority for the local government. LOMWRU’s Dr Mayfong Mayxay is the principal investigator (PI) for the Lao PDR study, while Dr Koukeo Phommasone is the field site PI.

Similar stories

New antibiotic combination speeds recovery from severe scrub typhus, which infects 1 million people per year

Treating patients ill with severe scrub typhus – a life-threatening infection that kills tens of thousands of people a year - with a combination of intravenous antibiotics doxycycline and azithromycin is significantly more effective than the current monotherapy of using either drug alone, say researchers in a study published in the New England Journal of Medicine (NEJM).

Watch our webinar - Radical cure of vivax malaria: can we do better?

The three presentations and expert discussion by Dr Rob Commons, Dr Alison Roth and Dr James Watson, chaired by Professor Sir Nicholas White (Mahidol Oxford Research Unit) and Dr Chau Nguyen Hoang (Oxford University Clinical Research Unit), are now available.

Study supports evidence ivermectin not effective to treat COVID-19

21 Feb 2023 Oxford UK - High doses of the drug ivermectin, controversially recommended by some high-profile political and media figures during the COVID-19 pandemic, is ineffective at treating the COVID-19 virus, say University of Oxford-affiliated researchers in a study published today in eLife.

Phase II Malaria vaccine trial begins in Thailand

The Mahidol Oxford Tropical Medicine Research Unit (MORU) has begun a Phase II trial to demonstrate that R21/matrix M is well-tolerated and immunogenic when administered with the antimalarial drug combination.

Pilot study detects diverse DNA in ingredients of falsified tablets

A recent multidisciplinary pilot study, originating from LOMWRU and the Medicine Quality Research Group of IDDO and MORU, investigated whether bacterial, plant, fungal and animal DNA in the ingredients and from the environment (eDNA) could be detected from falsified (aka counterfeit) tablets.

Ricardo Aguas awarded Associate Professorship

We are delighted to announce that Ricardo Aguas has been awarded the Associate Professor title, in recognition of his achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.